Posts

Showing posts with the label Interviews

Paul Turner on the Next Decade of Phage Therapy: Clinical Trials, Engineered Phages and Global Access

Image
Phage therapy is entering a period in which the central questions are no longer limited to whether bacteriophages can kill antibiotic-resistant bacteria. The field is increasingly confronting harder translational questions: which phages should be used, whether natural isolates or engineered viruses will ultimately dominate, how safety should be assessed, how clinical efficacy can be demonstrated, and how phage therapy can become accessible beyond a small number of specialist centers. Source :  https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTZ0kF9EL6WWX6Rr3fwUt2-v_9i2q3bmFQmoIlaWlW8Zh-KoefWs18muoo&s=10 In a new episode of New England Biolabs’ Lessons from Lab & Life podcast, Paul Turner, Rachel Carson Professor of Ecology and Evolutionary Biology at Yale University and a faculty member at Yale School of Medicine, discusses where he thinks the field is heading over the next five to ten years. Turner studies the evolutionary genetics of viruses and has become a major f...

Ami Bhatt Links Gut Phages, Hospital Superbugs and Recombinases for In Vivo CAR-T Engineering

Image
Ami Bhatt’s research at Stanford connects three problems that are usually studied separately: the origin of bloodstream infections in immunocompromised patients, rapid genome evolution in hospital-adapted bacteria, and the use of microbial recombinases to engineer human cells. In a September 2026 episode of Stanford Medicine’s The Future of Medicine , Bhatt described how her group studies microbial communities as evolving genomic systems rather than static lists of bacterial species. The laboratory focuses particularly on mobile genetic elements, including transposable elements and bacteriophages, because these sequences can alter bacterial genomes over clinically relevant timescales. Source of the image :  https://medicine.stanford.edu/news/stories/episodes/ami-bhatt-microbiome-superbugs-cancer-therapy.html One major application is hematopoietic cell transplantation. These patients receive combinations of chemotherapy, immunosuppressive drugs and broad-spectrum antibiotics that c...

Phage therapy: from a renaissance to a therapeutic revolution

Image
Phage therapy: from a renaissance to a therapeutic revolution Initially described as the "rebirth of an old treatment," phage therapy is now undergoing a true revolution. Driven by the urgency of antibiotic resistance, this century-old approach is now part of the modern therapeutic arsenal.  Phages specifically target a bacterium, replicate within it, and lyse it to spread.  Royalty-free / iStock / Getty Images Plus / via Getty Images Summary Phage therapy relies on the use of bacteriophages, natural viruses that specifically target a bacterium, within which they replicate to spread. Their specificity protects commensal bacteria, and their ability to self-magnify at the injection site gives them unique pharmacokinetic characteristics. In France, phage therapy has seen significant growth over the past five years, thanks to the development of pharmaceutical-grade phages. These can be used on a compassionate basis in clinical situations where life or function is at risk (complex...

Interviews : “Treatment with bacteriophages can combat antibiotic-resistant infections, but Swiss patients lack access”

Image
“Treatment with bacteriophages can combat antibiotic-resistant infections, but Swiss patients lack access” It is not only antibiotics but also certain viruses – known as bacteriophages – that can kill off pathogenic bacteria. However, Switzerland lacks the legal framework for the use of these viruses in therapy. What would need to change so that more patients can benefit from this form of treatment? Researcher Alexander Harms explains.  Alexander Harms is Professor of Molecular Phage Biology. (Image: Montage Giulia Marthaler / Fabienne Estermann) Bacteriophages – or phages for short – are viruses that can infect and kill off bacteria. They are naturally present in their billions in our environment, as well as with bacteria in our intestines and on our skin. Physicians have been using phages to combat pathogenic bacteria for over 100 years. This form of treatment was – and continues to be – particularly widespread in Georgia. Following the discovery of antibiotics, phage therap...

For beginners, students and interviews : Interview with Bassim Karaman (patient) on phage therapy

Image
Interview with Bassim Karaman on phage therapy Bassim Karaman recounts his medical journey after undergoing knee replacement surgery and developing an infection. Karaman was treated with phages at the Geneva University Hospitals, which most likely saved him from having to have his leg amputated. More information at https://forumphage.ch 0:00 What happened after the knee replacement 3:54 Living with an infection and no joint in his left knee 4:51 Dead end 5:46 The hope of phage therapy 6:24 Phage treatment 7:10 Effects of treatment 8:02 After phage treatment: one in two germs reappears 9:15 Three years later 10:35 But osteoarthritis remains 11:18 Is there a need for phage therapy?

Most Consulted Articles

Bacteriophages Disarm Inflammation-Associated E. coli Without Erasing the Gut Microbiome in IBD

🌐 PhageAtLabs® — a global interactive mapping of academic laboratories in phage research.

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

The Phage Therapy in the spotlight !

Phagos Launches CAPHARD, a 900-Million-Parameter AI Model to Predict Phage–Bacteria Interactions